Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen H Wright

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Molecular Pharmacology|September 10, 2021
Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary SitesSiennah R Miller, Meghan E McGrath, Kimberley M Zorn, et al.
Pharmaceutical Research|March 21, 2015
Unstirred Water Layers and the Kinetics of Organic Cation TransportTakahiro Shibayama, Mark Morales, Xiaohong Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 8, 2011
Characterization of the inhibitory effects of N-butylpyridinium chloride and structurally related ionic liquids on organic cation transporters 1/2 and human toxic extrusion transporters 1/2-k in vitro and in vivoYaofeng Cheng, Lucy J Martinez-Guerrero, Stephen H Wright, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic SteatohepatitisKayla L Frost, Joseph L Jilek, Erica L Toth, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2013
Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1David M Klein, Kristen K Evans, Rhiannon N Hardwick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 13, 2020
Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2Siennah R Miller, Raymond K Hau, Joseph L Jilek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2021
Attenuated Ochratoxin A Transporter Expression in a Mouse Model of Nonalcoholic Steatohepatitis Protects against Proximal Convoluted Tubule ToxicityJoseph L Jilek, Kayla L Frost, Solène Marie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2022
Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral CombinationKayla L Frost, Joseph L Jilek, Shripad Sinari, et al.
ACS Omega|April 10, 2023
Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and PyronaridinePatricia A Vignaux, Thomas R Lane, Ana C Puhl, et al.
Current Medicinal Chemistry|March 15, 2006
New methods for medicinal chemistry--universal gene cloning and expression systems for production of marine bioactive metabolitesWalter C Dunlap, Marcel Jaspars, Daslav Hranueli, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Molecular Pharmacology|September 10, 2021
Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary SitesSiennah R Miller, Meghan E McGrath, Kimberley M Zorn, et al.
Pharmaceutical Research|March 21, 2015
Unstirred Water Layers and the Kinetics of Organic Cation TransportTakahiro Shibayama, Mark Morales, Xiaohong Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 8, 2011
Characterization of the inhibitory effects of N-butylpyridinium chloride and structurally related ionic liquids on organic cation transporters 1/2 and human toxic extrusion transporters 1/2-k in vitro and in vivoYaofeng Cheng, Lucy J Martinez-Guerrero, Stephen H Wright, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic SteatohepatitisKayla L Frost, Joseph L Jilek, Erica L Toth, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2013
Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1David M Klein, Kristen K Evans, Rhiannon N Hardwick, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 13, 2020
Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2Siennah R Miller, Raymond K Hau, Joseph L Jilek, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2021
Attenuated Ochratoxin A Transporter Expression in a Mouse Model of Nonalcoholic Steatohepatitis Protects against Proximal Convoluted Tubule ToxicityJoseph L Jilek, Kayla L Frost, Solène Marie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2022
Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral CombinationKayla L Frost, Joseph L Jilek, Shripad Sinari, et al.
ACS Omega|April 10, 2023
Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and PyronaridinePatricia A Vignaux, Thomas R Lane, Ana C Puhl, et al.
Current Medicinal Chemistry|March 15, 2006
New methods for medicinal chemistry--universal gene cloning and expression systems for production of marine bioactive metabolitesWalter C Dunlap, Marcel Jaspars, Daslav Hranueli, et al.
Pageof 9